Cellular mechanisms underlying obesity-induced arterial stiffness

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Cellular Biology

Background:

• Obesity is a global pandemic linked to Western diets and sedentary lifestyles.
• Arterial stiffness in obesity predicts cardiovascular disease (CVD), cognitive decline, and chronic kidney disease.
• Cardiovascular stiffness precedes atherosclerosis, hypertension, and impaired blood flow.

Purpose of the Study:

• To highlight the cellular mechanisms of obesity-associated arterial stiffness.
• To review the role of aldosterone and mineralocorticoid receptor activation in arterial stiffness.

Main Methods:

• Review of existing research over the past 5 years.
• Focus on cellular mechanisms including endothelial and smooth muscle cell stiffness, extracellular matrix remodeling, and inflammation.
• Examination of nitric oxide bioavailability and oxidative stress.

Main Results:

• Obesity-associated arterial stiffness is linked to endothelial dysfunction, impaired nitric oxide generation, and increased oxidative stress.
• Increased aldosterone and vascular mineralocorticoid receptor activation are key drivers of cardiovascular stiffness.
• Premenopausal women with obesity, insulin resistance, and diabetes lose CVD protection due to increased arterial stiffness.

Conclusions:

• Cellular changes in obesity promote arterial stiffness, increasing cardiovascular risk.
• Aldosterone and mineralocorticoid receptor pathways are critical targets for mitigating obesity-related arterial stiffness.
• Understanding these mechanisms is crucial for preventing CVD in obese populations, especially women.